Shares of Morgan Stanley (NYSE: MS) declined in pre-market trading on Wednesday, after the company reported a decline in its fourth-quarter net profit.
The results came amid an exciting earnings season. Here are some key analyst takeaways from the earnings release.
- BMO Capital Markets analyst James Fotheringham maintained an Outperform rating, while raising the price target from $106 to $107.
- Oppenheimer analyst Chris Kotowski reiterated an Outperform rating, while raising the price target from $106 to $107.
- JMP Securities analyst Devin Ryan reaffirmed a Market Outperform rating on the stock.
Check out other analyst stock ratings.
BMO Capital Markets: Morgan Stanley’s higher-than-expected wealth management revenues and investment banking fees, along with slightly lower credit costs, more than offset its lower-than-anticipated trading revenues and higher compensation costs in the fourth quarter, Fotheringham said in a note.
“Relative ...